Connect with us

Company News

Boule appoints Holger Lembrér as CFO

Boule Diagnostics AB appoints Holger Lembrér as new CFO to take office in January 2024.

Holger has a long career in various senior finance positions within the ASSA ABLOY Group. He has a solid financial foundation from being CFO for a business area, responsible for investor relations and Financial Controller for the group. He has implemented profitability improvements and driven strategic projects with great success. Holger has also worked as an accountant at EY and is currently CFO for Oncopeptides.

“I am really looking forward to becoming part of the team at Boule and working together to continue developing the company forward. It feels inspiring to join a company with long experience, expertise, and strong brands in its industry,” says Holger Lembrér.

“I am convinced that Holger will contribute with new perspectives and strengthen the management at Boule, with his experience from a reputable listed company with its own manufacturing and global sales,” says President and CEO Jesper Söderqvist.

Current interim CFO Jan Benjaminson will continue in his role until Holger Lembrér takes over in early 2024.
MB Bureau

Copyright © 2024 Medical Buyer

error: Content is protected !!